STAT+: Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interest

The Government Accountability Office found that the FDA has not finalized guidance on financial conflicts of interest for advisory committee members 13 years after being required by law. This lack of transparency impacts developers and tech professionals who rely on clear regulatory standards for navigating potential conflicts in clinical trials and drug approvals. The GAO recommends setting a timeframe to finalize and publicly share this guidance, which should be closely watched for future compliance and transparency improvements.

Read the full article at STAT Pharma

---

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.